Your browser doesn't support javascript.
loading
Germline Variants in Patients Affected by Both Uveal and Cutaneous Melanoma.
Johansson, Peter A; Palmer, Jane M; McGrath, Lindsay; Warrier, Sunil; Hamilton, Hayley R; Beckman, Timothy; D'Mellow, Matthew G; Brooks, Kelly M; Glasson, William; Hayward, Nicholas K; Pritchard, Antonia L.
Afiliação
  • Johansson PA; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Palmer JM; University of Queensland, Brisbane, Queensland, Australia.
  • McGrath L; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Warrier S; Queensland Ocular Oncology Service, The Terrace Eye Centre, Brisbane, Queensland, Australia.
  • Hamilton HR; Queensland Ocular Oncology Service, The Terrace Eye Centre, Brisbane, Queensland, Australia.
  • Beckman T; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • D'Mellow MG; Queensland Ocular Oncology Service, The Terrace Eye Centre, Brisbane, Queensland, Australia.
  • Brooks KM; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Glasson W; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Hayward NK; University of Queensland, Brisbane, Queensland, Australia.
  • Pritchard AL; Queensland Ocular Oncology Service, The Terrace Eye Centre, Brisbane, Queensland, Australia.
Article em En | MEDLINE | ID: mdl-39315505
ABSTRACT
Uveal melanoma (UM) and nonacral cutaneous melanoma (CM) are distinct entities with varied genetic landscapes despite both arising from melanocytes. There are, however, similarities in that they most frequently affect people of European ancestry, and high penetrance germline variants in BAP1, POT1 and CDKN2A have been shown to predispose to both UM and CM. This study aims to further explore germline variants in patients affected by both UM and CM, shedding light on the underlying genetic mechanism causing these diseases. Using exome sequencing we analysed germline DNA samples from a cohort of 83 Australian patients diagnosed with both UM and CM. Eight (10%) patients were identified that carried pathogenic mutations in known melanoma predisposition genes POT1, MITF, OCA2, SLC45A2 and TYR. Three (4%) patients carried pathogenic variants in genes previously linked with other cancer syndromes (ATR, BRIP1 and MSH6) and another three cases carried monoallelic pathogenic variants in recessive cancer genes (xeroderma pigmentosum and Fanconi anaemia), indicating that reduced penetrance of phenotype in these individuals may contribute to the development of both UM and CM. These findings highlight the need for further studies characterising the role of these genes in melanoma susceptibility.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article